GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $12.37 $18.22 Friday, 19th Apr 2024 URGN stock ended at $13.73. This is 3.72% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 8.43% from a day low at $13.17 to a day high of $14.28.
90 days $12.37 $19.87
52 weeks $8.69 $24.13

Historical UroGen Pharma Ltd prices

Date Open High Low Close Volume
2024-04-19 $14.06 $14.28 $13.17 $13.73 380 995
2024-04-18 $14.36 $14.54 $13.96 $14.26 308 514
2024-04-17 $14.61 $14.66 $14.02 $14.24 169 601
2024-04-16 $14.86 $15.05 $14.16 $14.49 401 866
2024-04-15 $15.32 $15.43 $14.21 $15.10 657 208
2024-04-12 $13.09 $15.21 $13.00 $15.10 1 215 467
2024-04-11 $13.14 $13.25 $12.37 $13.25 252 393
2024-04-10 $13.20 $13.20 $12.58 $12.95 307 233
2024-04-09 $13.32 $13.91 $13.21 $13.37 200 976
2024-04-08 $13.64 $13.64 $13.18 $13.21 122 922
2024-04-05 $13.54 $13.97 $13.21 $13.60 127 582
2024-04-04 $13.77 $14.30 $13.50 $13.64 211 015
2024-04-03 $14.00 $14.26 $13.47 $13.66 170 760
2024-04-02 $14.28 $14.52 $13.00 $14.09 188 420
2024-04-01 $14.75 $14.75 $14.16 $14.20 179 151
2024-03-28 $14.92 $15.25 $14.56 $15.00 168 410
2024-03-27 $15.59 $15.59 $14.46 $14.96 248 861
2024-03-26 $16.80 $16.85 $14.99 $15.17 385 908
2024-03-25 $16.19 $18.22 $16.00 $16.66 889 314
2024-03-22 $14.89 $16.17 $14.73 $15.76 2 249 620
2024-03-21 $14.88 $15.09 $14.57 $14.94 136 509
2024-03-20 $14.98 $15.17 $14.37 $14.96 201 612
2024-03-19 $14.39 $15.23 $14.18 $15.02 271 420
2024-03-18 $14.50 $14.58 $13.83 $14.50 278 548
2024-03-15 $14.49 $14.84 $13.86 $14.46 387 506
Click to get the best stock tips daily for free!

About UroGen Pharma Ltd

UroGen Pharma Ltd UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms... URGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT